FDA denies emergency use nod for Covaxin in US

The US Food and Drug administration has denied approval for emergency use of Bharat Biotech’s Covaxin, and has asked for additional data, biopharmaceutical Ocugen, the US partner of the Indian vaccine maker has said.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.